Cystatin f regulates proteinase activity in il-2-activated natural killer cells

Protein and Peptide Letters

Volumn 21, Issue 9, 2014, Pages 957-965

  Maher, Katarina ^a   Konjar, Špela ^a   Watts, Colin ^b   Turk, Boris ^a   Kopitar Jerala, Nataša ^a  

^a JO EF STEFAN INSTITUTE   (Slovenia)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Cathepsin C.; Cathepsin V; Cystatin F; Natural Killer Cells

Indexed keywords

CATHEPSIN V; CYSTATIN; CYSTATIN F; DIPEPTIDYL PEPTIDASE I; INTERLEUKIN 2; PROTEINASE; UNCLASSIFIED DRUG; (3-ETHOXYCARBONYLOXIRANE-2-CARBONYL)LEUCINE (3-METHYLBUTYL) AMIDE; CST7 PROTEIN, HUMAN; ENZYME INHIBITOR; LEUCINE; PEPTIDE HYDROLASE; TUMOR MARKER;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL GRANULE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; LYMPHOCYTE ACTIVATION; MOLECULAR DYNAMICS; NATURAL KILLER CELL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; UPREGULATION; ANALOGS AND DERIVATIVES; CELL CULTURE; CONFOCAL MICROSCOPY; DRUG EFFECTS; ENZYME ACTIVATION; ENZYMOLOGY; HUMAN; METABOLISM; WESTERN BLOTTING;

BLOTTING, WESTERN; CELLS, CULTURED; CYSTATINS; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; INTERLEUKIN-2; KILLER CELLS, NATURAL; LEUCINE; MICROSCOPY, CONFOCAL; PEPTIDE HYDROLASES; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84906267525     PISSN: 09298665     EISSN: 18755305     Source Type: Journal    
DOI: 10.2174/0929866521666140403124146     Document Type: Article

References (45)

1. Yokoyama, W.M.; Kim, S.; French, A.R. The Dynamic Life of Natural Killer Cells. Annu. Rev. Immunol, 2004, 22(1), 405-429
2. Lodoen, M.B.; Lanier, L.L. Natural killer cells as an initial defense against pathogens. Curr. Opin. Immunol, 2006, 18(4), 391-398
3. Bird, P.I.; Trapani, J.A.; Villadangos, J.A. Endolysosomal proteases and their inhibitors in immunity. Nat. Rev. Immunol, 2009, 9(12), 871-882
4. Sutton, V.R.; Trapani, J.A. Proteases in lymphocyte killer function: redundancy, polymorphism and questions remaining. Biol Chem., 2010, 391(8), 873-9
5. Colbert, J.D.; Matthews, S.P.; Miller, G.; Watts, C. Diverse regulatory roles for lysosomal proteases in the immune response. Eur. J. Immunol, 2009, 39(11), 2955-2965
6. Stoeckle, C; Gouttefangeas, C; Hammer, M.; Weber, E.; Melms, A.; Tolosa, E., Cathepsin W expressed exclusively in CD8+ T cells and NK cells, is secreted during target cell killing but is not essential for cytotoxicity in human CTLs. Exp. Hematol, 2009, 37(2), 266-275
7. Meade, J.L.; Wilson, E.B.; Holmes, T.D.; de Wynter, E.A.; Brett, P.; Straszynski, L.; Ballard, P.A.S.; Trapani, J.A.; McDermott, M.F.; Cook, G.P. Proteolytic Activation of the Cytotoxic Phenotype during Human NK Cell Development. J. Immunol, 2009, 183(2), 803-813
8. Baran, K; Ciccone, A.; Peters, C; Yagita, H; Bird, P.I.; Villadangos, J.A.; Trapani, J.A. Cytotoxic T Lymphocytes from Cathepsin B-deficient Mice Survive Normally in vitro and in vivo after Encountering and Killing Target Cells. J. Biol. Chem., 2006, 281(41), 30485-30491
9. Konjar, S.; Sutton, V.R.; Hoves, S.; Repnik, U.; Yagita, H; Reinheckel, T.; Peters, C; Turk, V.; Turk, B.; Trapani, J.A.; Kopitar-Jerala, N. Human and mouse perforin are processed in part through cleavage by the lysosomal cysteine proteinase cathepsin L. Immunology, 2010, 131(2), 257-267
10. Puente, X.S.; Sanchez, L.M.; Overall, CM.; Lopez-Otin, C. Human and mouse proteases: A comparative genomic approach. Nat. Rev. Genet., 2003, 4(7), 544-558
11. Bromme, D.; Li, Z.; Barnes, M.; Mehler, E. Human cathepsin V functional expression, tissue distribution, electrostatic surface potential, enzymatic characterization, and chromosomal localization. Biochemistry, 1999, 38(8), 2377-85
12. Kopitar-Jerala, N. The role of cystatins in cells of the immune system. FEBS Lett., 2006, 580, 6295-6301
13. Turk, V.; Stoka, V.; Turk, D. Cystatins: biochemical and structural properties, and medical relevance. Front. Biosci., 2008, 13, 5406-5420
14. Lenarčič, B.; Bevec, T. Thyropins-new structurally related proteinase inhibitors. Biol. Chem., 1998, 379(2), 105-11
15. Turk, B.; Turk, D.; Salvesen, G.S. Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators. Curr. Pharm. Des., 2002, 8(18), 1623-37
16. Langerholc, T.; Zavasnik-Bergant, V.; Turk, B.; Turk, V.; Abrahamson, M.; Kos, J., Inhibitory properties of cystatin F and its localization in U937 promonocyte cells. FEBS J., 2005, 272(6), 1535-1545
17. Schüttelkopf, A.W.; Hamilton, G.; Watts, C; van Aalten, D.M.F. Structural Basis of Reduction-dependent Activation of Human Cystatin F. J. Biol. Chem., 2006, 281(24), 16570-16575
18. Halfon, S. Leukocystatin, a new class II cystatin expressed selectively by hematopoietic cells. J. Biol. Chem., 1998, 273, 16400-16408
19. Obata-Onai, A.; Hashimoto, S.; Onai, N; Kurachi, M.; Nagai, S.; Shizuno, K.; Nagahata, T.; Matsushima, K. Comprehensive gene expression analysis of human NK cells and CD8(+) T lymphocytes. Int. Immunol, 2002, 14, 1085-1098
20. Ni, J.; Fernandez, A.; Danielsson, L.; Chillakuru, R.A.; Zhang, J.; Grub, A.; Su, J.; Gentz, R.; Abrahamson, M. Cystatin F is a glycosylated human low molecular weight cystein proteinase inhibitor. J. Biol. Chem., 1998, 273, 24797-24804
21. Cappello, F.; Gatti, E.; Camossetto, V.; David, A.; Lelouard, H; Pierre, P. Cystatin F is secreted, but artificial modification of its C-terminus can induce its endocytic targeting. Exp. Cell Res., 2004, 297, 607-618
22. Colbert, J.D.; Plechanovová, A.; Watts, C. Glycosylation Directs Targeting and Activation of Cystatin F from Intracellular and Extracellular Sources. Traffic, 2009, 10(4), 425-437
23. Alvarez-Fernandez, M.; Barrett, A.J.; Gerhartz, B.; Dando, P.M.; Ni, J.; Abrahamson, M. Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site. J. Biol. Chem., 1999, 272, 19195-19203
24. Hamilton, G.; Colbert, J.D.; Schuettelkopf, A.W.; Watts, C. Cystatin F is a cathepsin C-directed protease inhibitor regulated by proteolysis. EMBO J., 2008, 27(3), 499-508
25. Salcedo, T.; Azzoni, L.; Wolf, S.; Perussia, B. Modulation of perforin and granzyme messenger RNA expression in human natural killer cells. J. Immunol, 1993, 151(5), 2511-2520
26. Janas, M.L.; Groves, P.; Kienzle, N; Kelso, A. IL-2 Regulates Perforin and Granzyme Gene Expression in CD8+ T Cells Independently of Its Effects on Survival and Proliferation. J. Immunol, 2005, 175(12), 8003-8010
27. Kopitar-Jerala, N; Bevec, T.; Barlic-Maganja, D.; Gubensek, F.; Turk, V. Anti-cathepsin L monoclonal antibodies that distinguish cathepsin L from cathepsin V. Biol. Chem., 2001, 382(5), 867-70
28. Konjar, Š; Yin, F.; Bogyo, M.; Turk, B.; Kopitar-Jerala, N. Increased nucleolar localization of SpiA3G in classically but not alternatively activated macrophages. FEBS Lett., 2010, 584(11), 2201-2206
29. Čeru, S.; Konjar, S.; Maher, K; Repnik, U.; Križaj, I.; Benčina, M.; Renko, M.; Nepveu, A.; Žerovnik E.; Turk, B.; Kopitar-Jerala, N. Stefin B Interacts with Histones and Cathepsin L in the Nucleus. J. Biol. Chem., 2010, 285(13), 10078-10086
30. Rozman-Pungercar, J.; Kopitar-Jerala, N; Bogyo, M.; Turk, D.; Vasiljeva, O.; Stefe, I.; Vandenabeele, P.; Bromme, D.; Puizdar, V.; Fonovi, M.; Trstenjak-Prebanda, M.; Dolenc, I.; Turk, V.; Turk, B. Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: when reaction mechanism is more important than specificity. Cell Death Differ., 2003, 10(8), 881-8
31. Dahl, S.W.; Halkier, T.; Lauritzen, C.; Dolenc, I.; Pedersen, J.; Turk, V.; Turk, B. Human recombinant pro-dipeptidyl peptidase I (cathepsin C) can be activated by cathepsins L and S but not by autocatalytic processing. Biochemistry, 2001, 40, 1671-1678
32. Meade, J.L.; de Wynter, E.A.; Brett, P.; Sharif, S.M.; Woods, C.G.; Markham, A.F.; Cook, G.P. A family with Papillon-Lefevre syndrome reveals a requirement for cathepsin C in granzyme B activation and NK cell cytolytic activity. Blood, 2006, 107, 3665-3668
33. Henney, C.S.; Kuribayashi, K.; Kern, D.E.; Gillis, S. Interleukin-2 augments natural killer cell activity. Nature, 1981, 291(5813), 335-8
34. Kuribayashi, K.; Gillis, S.; Kern, D.E.; Henney, C.S. Murine NK cell cultures: effects of interleukin-2 and interferon on cell growth and cytotoxic reactivity. J. Immunol., 1981, 126(6), 2321-7
35. Sexton, K.B.; Witte, M.D.; Blum, G.; Bogyo, M. Design of cell-permeable, fluorescent activity-based probes for the lysosomal cysteine protease asparaginyl endopeptidase (AEP)/legumain. Bioorg. Med. Chem. Lett., 2007, 17(3), 649-653
36. Yasuda, Y.; Li, Z.; Greenbaum, D.; Bogyo, M.; Weber, E.; Bromme, D. Cathepsin V, a novel and potent elastolytic activity expressed in activated macrophages. J. Biol. Chem., 2004, 279(35), 36761-70
37. Tolosa, E.; Li, W.; Yasuda, Y.; Wienhold, W.; Denzin, L.K.; Lautwein, A.; Driessen, C.; Schnorrer, P.; Weber, E.; Stevanovic, S.; Kurek, R.; Melms, A.; Brömme, D. Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis. J. Clin. Invest., 2003, 112(4), 517-526
38. Shirahama-Noda, K.; Yamamoto, A.; Sugihara, K.; Hashimoto, N.; Asano, M.; Nishimura, M.; Hara-Nishimura, I. Biosynthetic Processing of Cathepsins and Lysosomal Degradation Are Abolished in Asparaginyl Endopeptidase-deficient Mice. J. Biol. Chem., 2003, 278(35), 33194-33199
39. Colbert, J.D.; Matthews, S.P.; Kos, J.; Watts, C. Internalisation of exogenous cystatin F suppresses cysteine proteases and induces the accumulation of single-chain cathepsin L by multiple mechanisms. J. Biol. Chem., 2011, 286(49), 42082-90
40. Pham, C.T.N.; Armstrong, R.J.; Zimonjic, D.B.; Popescu, N.C.; Payan, D.G.; Ley, T.J. Molecular Cloning, Chromosomal Localization, and Expression of Murine Dipeptidyl Peptidase I. J. Biol. Chem., 1997, 272(16), 10695-10703
41. Popovic, T.; Cimerman, N.; Dolenc, I.; Ritonja, A.; Brzin, J., Cathepsin L is capable of truncating cystatin C of 11 N-terminal amino acids. FEBS Lett., 1999, 455(1-2), 92-96
42. Olsson, S.-L.; Ek, B.; Björk, I. The affinity and kinetics of inhibition of cysteine proteinases by intact recombinant bovine cystatin C. Biochim. Biophys. Acta, 1999, 1432(1), 73-81
43. Puzer, L.; Cotrin, S.S.; Alves, M.F.; Egborge, T.; Araujo, M.S.; Juliano, M.A.; Juliano, L.; Bromme, D.; Carmona, A.K. Comparative substrate specificity analysis of recombinant human cathepsin V and cathepsin L. Arch. Biochem. Biophys., 2004, 430(2), 274-83
44. Lenarčič, B.; Kos, J.; Dolenc, I.; Lučovnik, P.; Križaj, I.; Turk, V. Cathepsin D inactivates cysteine proteinase inhibitors cystatins. Biochem. Biophys. Res. Commun., 1988, 154(2), 765-772
45. Lenarčič, B.; Krašovec, M.; Ritonja, A.; Olafsson, I.; Turk, V. Inactivation of human cystatin C and kininogen by human cathepsin D. FEBS Lett., 1991, 280(2), 211-215.